Amgen Publishes Asthma Drug Proof-of-Concept in NEJM – Drug Discovery & Development


Drug Discovery & Development

Amgen Publishes Asthma Drug Proof-of-Concept in NEJM
Drug Discovery & Development
Amgen announced that The New England Journal of Medicine (NEJM) published positive results from a Phase 1 study adding to the growing body of evidence that inhibiting thymic stromal lymphopoietin (TSLP) could be beneficial in the treatment of asthma.
Novel Antibody Demonstrates Promise against AsthmaGenetic Engineering News
Amgen drug for allergy asthma shows promise in early testsSFGate
Novel Biologic Promising for Allergic AsthmaMedPage Today
News-Medical.net –Daily Digest
all 31 news articles »

View full post on asthma – Google News

Vermont publishes asthma data and state plan on World Asthma Day – VTDigger – vtdigger.org

Vermont publishes asthma data and state plan on World Asthma Day – VTDigger
vtdigger.org
BURLINGTON – Vermont, a rural state known for its open spaces, clean air and relative absence of industrialization, has one of the highest rates of asthma in the nation. One in 10 Vermont children and approximately 11 percent of adults had asthma in 2010.

View full post on asthma – Google News

The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study … – PR Newswire (press release)

The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study
PR Newswire (press release)
Cytos Biotechnology Ltd (SIX:CYTN) today announced the publication of the results from its phase 2a clinical trial with CYT003-QbG10 (CYT003), a first-in-class immune modulator in clinical development as a potential new treatment for allergic asthma.

and more »

View full post on asthma – Google News